Stryker nabs former DePuy CEO to lead ortho division | Personnel Moves

 Stryker hires former DePuy CEO to lead orthopedics
Orthopedic giant Stryker (NYSE:SYK) appointed David Floyd, former CEO for rival device maker DePuy Orthopaedics, to lead as group president of its orthopedics division.  

In March Floyd stepped down as chief executive of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy amid the fallout over the ASR hip implant recall, after which he took over as CEO of OrthoWorx.

Floyd left to pursue outside interests, DePuy officials said at the time. He had started with DePuy in September 2007, and left during a damaging metal-on-metal hip controversy that had already cost the company $1 billion by the time Floyd stepped down.

Floyd is joining Stryker, effective November 15, where he will oversee the company’s reconstructive, trauma & extremities, joint preservation, orthobiologics and performance solutions businesses.
Read more

 ConforMIS names Traynor its new CFO
Privately held joint health devices maker ConforMIS named Peter Traynor its new CFO. Traynor spent 10 years as chief accounting officer for Genzyme Corp.
Read more

 Ortho devices maker Tornier announces CEO swap
Orthopedic devices maker Tornier (NSDQ:TRNX) announced that David Mowry would take over as president & CEO, effective immediately. Mowry succeeds Douglas Kohrs, who retired as president, CEO & executive director.
Read more

 Hologic approves increased salaries for executives
Breast imaging devices maker Hologic (NSDQ:HOLX) offered raises to a handful of its executives, including a new $927,000 salary for president & CEO Robert Cascella, $600,000 for CFO Glenn Muir and $400,000 for senior VP and breast health general manager Peter Soltani.
Read more

 Sanuwave chief resigns
Sanuwave Health (OTC:SNWV) president & CEO Christopher Cashman resigned his post, effective November 7, following which he will stay on as an advisor to the company for a period of 12 months.

Cashman’s severance package includes $100,000 milestone bonuses payable upon certain achievements related to the dermaPACE foot ulcer treatment.
Read more

 Long-time Syneron board member Marshall Butler dies
Global aesthetic device manufacturer Syneron Medical (NSDQ:ELOS) noted the death of  board member Marshall Butler, who had been with the company since its inception.
Read more